Director/PDMR Shareholding
PDMR DEALING NOTIFICATION |
|||
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them |
|||
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||
a) |
Name |
Jonathan Peacock |
|
2 |
Reason for the notification |
||
a) |
Position / status |
Chairman |
|
b) |
Initial notification / Amendment |
Initial Notification |
|
3 |
Details of issuer |
||
a) |
Name |
Arix Bioscience plc |
|
b) |
LEI |
213800OVT3AHQCXNIX43 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares of Arix Bioscience plc |
|
Identification code |
GB00BD045071 |
||
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
225.00 pence |
90,000 |
||
d) |
Aggregated information |
Aggregated price |
Aggregated volume |
N/A (single transaction) |
N/A (single transaction) |
||
e) |
Date of the transaction |
20 March 2018 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
For further information:
James Rawlingson Chief Financial Officer +44 (0)207 290 1050
- Ends -